Skip to main content
Experimental and Therapeutic Medicine logoLink to Experimental and Therapeutic Medicine
. 2014 Jun 24;8(3):781–784. doi: 10.3892/etm.2014.1804

Characteristics and risk factor analysis of 410 cases of tracheobronchial tuberculosis

XINMEI GUO 1,, CHUNYAN WANG 1, XIAOPING WANG 1, JUAN MA 1, LI XV 1, TINGTING LUAN 1, CHANGWEI KOU 1
PMCID: PMC4113521  PMID: 25120599

Abstract

The present study analyzed the characteristics and risk factors associated with tracheobronchial tuberculosis (TBTB) in 410 patients with TBTB. Retrospective analysis was performed on the clinical features, bronchoscopy performance, bacteriological examination, imaging and treatment of 410 patients who were diagnosed with TBTB using bronchoscopy. Among the 410 patients, 10 patients underwent chest X-ray which revealed two cases of atelectasis, eight cases of patch or spot shadows, three cases of cavity, one case of nodule and one case with no abnormalities. The remaining 400 patients underwent computed tomography chest scans and/or airway reconstruction examinations. Among all the lesion types, the cavity type was found to be the most likely to cause bronchial stenosis or obstruction, with statistically significant differences when compared with the congestion, stenosis or scar lesion types (P<0.01). Moreover, for the cavity type, there were 194 sites of obstruction prior to therapy; however, only 23 sites of obstruction remained following therapy. Furthermore, there were 34 sites without stenosis prior to therapy and 205 sites without stenosis following therapy. The number of sites of obstruction was significantly decreased and the number of sites without stenosis was increased upon therapy. These findings suggest that the cavity type is the most sensitive type to therapy among the five types of TBTB lesion.

Keywords: tuberculosis, trachea, bronchus, bronchoscopy, chest computed tomography, etiology, prognosis

Introduction

Tuberculous bronchitis is a submucosal tuberculosis mainly found in bronchial mucosa and submucosa (1,2). Tuberculous bronchitis has also been diagnosed in smooth muscle, cartilage and outer membranes; thus it is termed tracheobronchial tuberculosis (TBTB) (3). TBTB may be misdiagnosed as bronchitis, asthma, bronchiectasis or lung cancer (4,5). TBTB is present in 10%-40% of patients with active pulmonary tuberculosis (6) and the incidence of TBTB has been increasing in recent years (7). TBTB is more common in young adults than older ones, and females are more readily infected than males (8). The onset of TBTB may be concealed and its clinical manifestations are not specific, which makes the diagnosis of TBTB difficult. Clinically (9), TBTB patients may have systematic respiratory symptoms such as severe cough, sputum, wheezing, hemoptysis and paroxysmal dyspnea. In TBTB patients with stenosis in the trachea, left and right main bronchus, and middle segment of bronchus, the cough sounds like barking. In certain patients, these symptoms may also be accompanied by systematic symptoms (such as fever, night sweats, anorexia, fatigue, weight loss and irregular menstruation) and allergic manifestations (such as allergic arthritis and conjunctivitis).

In the present study, a retrospective analysis of 410 patients with TBTB was performed in order to investigate the characteristics and risk factors associated with TBTB. The patients selected for the present study were enrolled at Shandong Chest Hospital (Jinan, China) between January and December 2012.

Materials and methods

Patients

The present study was approved by the Ethics Committee of Shandong University (Jinan, China). All patients provided written informed consent. None of the patients were long-term users of hormones for the treatment of autoimmune diseases, including cancer, AIDS, diabetes, systemic lupus erythematosus and organ transplantation.

Diagnosis

All patients underwent sputum acid-fast bacilli examination (three smears and one culture using the BACTEC method), electronic bronchoscopy and a chest X-ray or computed tomography (CT) scan. According to previously described criteria (3), the 410 patients met the following criteria: i) typical lesions of TBTB identified by bronchoscopy and ii) a positive sputum smear for acid-fast bacilli and/or a positive sputum culture for Mycobacterium tuberculosis; or bronchial brushing or bronchoalveolar lavage samples positive for acid-fast bacilli; or tuberculous pathological changes identified using bronchoscopic biopsy.

Treatment

Among the 410 patients with TBTB, 382 patients were newly diagnosed. The remaining 28 cases were patients who required retreatment. The registered patients adopted the 3HRZE/6HRE program (H, isoniazid; R, rifampicin; Z, pyrazinamide; E, ethambutol). The 28 patients requiring retreatment received the 3HRZEL/6HREL program supplemented with 0.2 g isoniazid inhalation therapy. The 410 patients were treated with endobronchial injection, clamping, balloon dilatation, refrigeration and other treatments. The patients with severe airway obstruction were administered bronchoscopic therapy under general anesthesia 2–15 times. The patients were followed up for between 3 and 9 months using bronchoscopy.

Bronchoscopy and TBTB typing

The diagnosis of TBTB was performed using bronchoscopy and bacteriological or pathological analysis results. In China, TBTB is classified into six pathological types, including the inflammatory infiltration type (Fig. 1A and B), the ulceration necrosis type (Fig. 1C and D), the proliferative granulation type (Fig. 1E and F), the scar stenosis type (Fig. 1G and H), the wall softening type (Fig. 1I and J) and the lymph fistula type (Fig. 1K–M) (10).

Figure 1.

Figure 1

The six pathological types of tracheobronchial tuberculosis. The six types consist of the (A and B) inflammatory infiltration, (C and D) ulceration necrosis, (E and F) proliferative granulation type, (G and H) scar stenosis type, (I and J) wall softening type and (K–M) lymph fistula types.

Imaging analysis

Among the 410 patients with TBTB, 10 patients received chest X-ray examination. The remaining 400 patients underwent spiral CT examination of the chest and/or airway reconstruction examinations.

Statistical analysis

SPSS software, version 21.0 (SPSS, Inc., Chicago, IL, USA) was used for the statistical analyses. Student’s t-tests and χ2 test were used for analysis of the differences between groups. P<0.05 was considered to indicate a statistically significant difference.

Results

Characteristics of patients

The present study included 109 male and 301 female patients in the total 410 patients with TBTB (Table I). The difference (109/301) between the number of males and the females was found to be significant (t=-2.357; P<0.001). Among the patients, 10 underwent chest X-ray, revealing two cases of atelectasis, eight cases of patch or spot shadows, three cases of cavity, one case of nodule and one patient with no abnormalities. The remaining 400 patients underwent chest CT scan and/or airway reconstruction examination. The results revealed 112 cases of partial or whole left lung atelectasis, 248 cases of bronchial stenosis, 135 cases of bronchial lumen obstruction, 255 cases of patch shadows, 179 cases of spot shadows, 124 cases of cavity, 34 cases of nodules, 134 cases of hilar and mediastinal lymph node enlargment, 65 cases of hilar or mediastinal lymph node calcification and 10 patients with no abnormal alterations.

Table I.

Comparison of lesion types in the 410 patients with tracheobronchial tuberculosis enrolled in the present study.

Gender Total number of lesions, n (%) Congestion, n (%) Granulation, n (%) Cavity, n (%) Stenosis, n (%) Scar, n (%) χ2 P-value
Male (n=109) 111 (26.2) 1 (0.2) 16 (3.8) 58 (13.7) 29 (6.8) 7 (1.7)
Female (n=301) 313 (73.8) 6 (1.4) 33 (7.8) 170 (40.1) 80 (18.9) 24 (5.7)
Total (n=410) 424 (100) 7 (1.7) 49 (11.6) 228 (53.8) 109 (25.7) 31 (7.3) 1.858 0.762

χ2 value and the P-value were calculated through comparing the pathological lesion types between the male and the female groups.

The bronchoscopy results indicated that among the 109 male patients, there was 1 congestion lesion, 16 granulation lesions, 58 cavity lesions, 29 stenosis lesions and 7 scar lesions among the five lesion types. Among the 301 female patients, there were 6 congestion lesions, 33 granulation lesions, 170 cavity lesions, 80 stenosis lesions and 24 scar lesions. Among all the lesion types, the cavity lesion type was found to be the most likely to cause bronchial stenosis or obstruction (Table II), with statistically significant differences observed compared with the congestion, stenosis and scar lesion types (P<0.01; Table II). These findings suggest that the cavity lesion type is the predominant risk factor.

Table II.

Changes in the bronchial lumen caused by tracheobronchial tuberculosis.

Changes in the bronchial lumen

Lesion type No stenosis, n (%) Stenosis, n (%) Obstruction, n (%) Total, n (%) χ2 P-value
Cavity 34 (5.1) 228 (34.4) 166 (25.1) 428 (64.7)
Congestion 4 (0.6) 3 (0.5) 0 (0) 7 (1.1) 21.940 <0.001
Granulation 8 (1.2) 26 (3.9) 15 (2.3) 49 (7.4) 4.283 0.117
Stenosis 0 (0) 109 (16.5) 38 (5.7) 147 (22.2) 24.976 <0.001
Scar 11 (1.7) 18 (2.7) 2 (0.3) 31 (4.7) 30.743 <0.001
Total 57 (8.6) 384 (58.0) 221 (33.4) 662 (100) 85.583 <0.001

χ2 value, cavity type compared with other types; P-value, cavity types compared with other types.

Comparison of the bronchoscopic therapies

The 410 patients with TBTB all received the aforementioned local treatments. There were statistically significant differences in the bronchial lumen for the granulation, cavity and congestion lesion types prior to and following therapy (P<0.01; Table III). However, there were no significant differences in bronchial lumen for the fibrous stenosis and scar lesions types prior to and following therapy, as shown in Table III. For the cavity type, there were 194 sites of obstruction prior to therapy and only 23 sites of obstruction following therapy (Table III). Furthermore, there were 34 sites without stenosis prior to therapy and 205 sites without stenosis following therapy. These results suggest that the cavity type is the most sensitive to therapy among the five lesion types. Moreover, the number of sites of obstruction was significantly decreased and the number of sites without stenosis was relatively increased following therapy.

Table III.

Changes in the bronchial lumen prior to and following therapy.

Lesion type -Lesion number (total 424) Prior to therapy Following therapy χ2 P-value


No stenosis, n (%) Stenosis and/or obstruction, n (%) No stenosis, n (%) Stenosis and/or obstruction, n (%)
Cavity 228 34 (8.0) 194 (45.8) 205 (48.3) 23 (5.4)
Congestion 7 4 (0.9) 3 (0.7) 7 (1.7) 0 (0) 470.000 <0.001
Granulation 49 8 (1.9) 41 (9.7) 44 (10.4) 5 (1.2) 554.000 0.009
Stenosis 109 0 (0) 109 (25.7) 58 (13.7) 51 (12.0) 674.000 <0.001
Scar 31 11 (2.6) 20 (4.7) 11 (2.6) 20 (4.7) 518.000 <0.001

χ2, cavity type compared with other types. P, cavity type compared with other types.

Discussion

In the present study, 400 patients underwent chest CT scan and/or airway reconstruction examinations, including 112 cases of partial or left whole lung atelectasis, 248 cases of bronchial stenosis and 135 cases of bronchial obstruction. X-ray examinations have no specificity for the diagnosis of TBTB (10,11). However, chest CT scans with airway reconstruction techniques are able to show stenosis and obstruction in the bronchial lumen and clearly demonstrate the extent and scope of the bronchial stenosis or obstruction, revealing the changes in the bronchial walls more clearly. In addition, using this method, it is possible to determine whether the hilar and mediastinal lymph nodes are enlarged or have calcification (6,13). Thus, CT scans with airway reconstruction techniques have clinical value for TBTB diagnosis.

In the present study, all patients underwent sputum smear microscopy three times in order to detect acid-fast bacilli and sputum culture once using the BACTEC method. There were 135 cases that were sputum smear positive and 177 cases that were sputum culture positive. All patients also underwent bronchoscopy and brushing for acid-fast bacilli sputum smear and mycobacterial culture one week following admission. There were 78 cases of patients who were acid-fast bacilli smear positive and 169 cases of patients who were brush mycobacterial culture positive among the 410 cases. There was no significant difference in the tuberculosis positive rate between the male and female patients.

TBTB is capable of invading bronchial tissue, submucosa, muscle, bronchial cartilage and outer membranes at many sites (3,1416). Bronchiolar involvement has been found to be common in the main bronchus and upper lobe bronchus, and is more common in the left than in the right (13). In the present study, bronchoscopy revealed that among the patients with TBTB, 193 patients had lesions located in one site and 217 cases had lesions in multiple sites, predominantly in the left main bronchus (32.7%). A moderate number of lesions were observed in the left upper lobe bronchus and the lowest number was found in the right lower lobe bronchus.

Among the five types of lesion, bronchoscopy examination in the present study revealed 7 congestion lesions, 49 granulation lesions, 228 cavity lesions, 109 stenosis lesions and 31 scar lesions. Furthermore, cavity lesions were found to be significantly more common than the other types of lesions (P<0.01).

In conclusion, the incidence of TBTB is associated with gender and age. Young women usually have a higher incidence and more serious disease. Among all the types of lesions, the cavity lesion type has the highest incidence. In addition, the cavity type is more likely to cause bronchial stenosis or obstruction. Bronchoscopy is an effective means for the diagnosis and treatment of TBTB and early bronchoscopy intervention is likely to achieve better results.

Acknowledgements

This study was supported by a grant from the Medicine and Health Care Technology Development Project of Shandong Province (grant no. 2013WS0147).

References

  • 1.Chung HS, Lee JH. Bronchoscopic assessment of the evolution of endobronchial tuberculosis. Chest. 2000;117:385–392. doi: 10.1378/chest.117.2.385. [DOI] [PubMed] [Google Scholar]
  • 2.Wang WB, Zhao Q, Yuan ZA, Jiang WL, Liu ML, Xu B. Deaths of tuberculosis patients in urban China: a retrospective cohort study. Int J Tuberc Lung Dis. 2013;17:493–498. doi: 10.5588/ijtld.12.0400. [DOI] [PubMed] [Google Scholar]
  • 3.Chinese Medical Association Tuberculosis Branch; Editorial Board of The Journal of Tuberculosis and Respiratory Disease. Tracheobronchial tuberculosis diagnosis and treatment guidelines (Trial) Chinese Journal of Tuberculosis and Respiratory Diseases. 2012;35:581–587. (In Chinese) [Google Scholar]
  • 4.Ehrlich RI, Adams S, Baatjies R, Jeebhay MF. Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies. Int J Tuberc Lung Dis. 2011;15:886–891. doi: 10.5588/ijtld.10.0526. [DOI] [PubMed] [Google Scholar]
  • 5.Watanabe A. Clinical manifestation of Q fever and tuberculosis, similarly caused by intracellular parasites. Kekkaku. 2006;81:543–549. (In Japanese) [PubMed] [Google Scholar]
  • 6.Kashyap S, Mohapatra PR, Saini V. Endobronchial tuberculosis. Indian J Chest Dis Allied Sci. 2003;45:247–256. [PubMed] [Google Scholar]
  • 7.Xue Q, Wang N, Xue X, Wang J. Endobronchial tuberculosis: an overview. Eur J Clin Microbiol Infect Dis. 2011;30:1039–1044. doi: 10.1007/s10096-011-1205-2. [DOI] [PubMed] [Google Scholar]
  • 8.Rikimaru T. Endobronchial tubereulosis. Expert Rev Anti Infect Ther. 2004;2:245–251. doi: 10.1586/14787210.2.2.245. [DOI] [PubMed] [Google Scholar]
  • 9.He RX, Zhao SY. Analysis of clinical manifestations and diagnosis of 102 children with bronchial tuberculosis. Zhonghua Er Ke Za Zhi. 2012;50:737–739. (In Chinese) [PubMed] [Google Scholar]
  • 10.Tang SJ, Xiao HP, Hu HL, et al. Clinical characteristic, diagnostic standard and types of endobronchial tuberculosis: An analysis of 278 cases. Chinese Journal of Clinicians (Electronic Edition) 2009;3:32–40. (In Chinese) [Google Scholar]
  • 11.Jung SW, Kim MW, Cho SK, et al. A case of endobronchial aspergilloma associated with foreign body in immunocompetent patient without underlying lung disease. Tuberc Respir Dis (Seoul) 2013;74:231–234. doi: 10.4046/trd.2013.74.5.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Verma A, Park HY, Lim SY, et al. Posttuberculosis tracheobronchial stenosis: use of CT to optimize the time of silicone stent removal. Radiology. 2012;263:562–568. doi: 10.1148/radiol.11111463. [DOI] [PubMed] [Google Scholar]
  • 13.Zhu XH, Shao J, You ZQ, et al. The diagnostic value of multi-slice spiral CT in endobronchial tuberculosis. Chinese Journal of Radiology. 2004;38:26–29. (In Chinese) [Google Scholar]
  • 14.Jiang HN, Zuo JM, He LX. The diagnosis and therapy advancement of tracheo-bronchial tuberculosis. Bulletin of the Chinese Antituberculosis Association. 2000;22:50–54. (In Chinese) [Google Scholar]
  • 15.Iwamoto Y, Miyazawa T, Kurimoto N, et al. Interventional bronchoscopy in the management of airway stenosis due to tracheobronchial tuberculosis. Chest. 2004;126:1344–1352. doi: 10.1378/chest.126.4.1344. [DOI] [PubMed] [Google Scholar]
  • 16.Chhajed PN, Malouf MA, Glanville AR. Bronchoscopic dilatation in the management of benign (non-transplant) tracheobronchial stenosis. Intern Med J. 2001;31:512–516. doi: 10.1046/j.1445-5994.2001.00135.x. [DOI] [PubMed] [Google Scholar]

Articles from Experimental and Therapeutic Medicine are provided here courtesy of Spandidos Publications

RESOURCES